Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.26 USD | -5.83% | -14.39% | +43.04% |
Business Summary
Number of employees: 37
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Novel Bispecific Antibodies
100.0
%
| 20 | 100.0 % | 7 | 100.0 % | -64.09% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Netherlands
100.0
%
| 20 | 100.0 % | 7 | 100.0 % | -64.09% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 19-05-31 | |
Fred M. Powell
DFI | Director of Finance/CFO | 63 | 22-10-31 |
Chief Tech/Sci/R&D Officer | - | 21-11-08 | |
Chief Tech/Sci/R&D Officer | 50 | 16-12-31 | |
Chief Tech/Sci/R&D Officer | 59 | 23-02-05 | |
Chief Tech/Sci/R&D Officer | 60 | 18-04-30 | |
Robin Hume
LAW | General Counsel | - | 23-05-14 |
Human Resources Officer | - | 21-11-08 | |
Amy Garabedian
LAW | General Counsel | - | 21-07-26 |
Peter Ros
PRN | Corporate Officer/Principal | 52 | 19-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 56 | 19-05-31 | |
Karen Wilson
BRD | Director/Board Member | 61 | 21-03-31 |
James Noble
BRD | Director/Board Member | 65 | 22-06-14 |
Peter Kiener
BRD | Director/Board Member | 72 | 22-12-31 |
Jay Backstrom
BRD | Director/Board Member | 69 | 22-06-14 |
Kapil Dhingra
CHM | Chairman | 64 | 21-02-21 |
Mary Wadlinger
BRD | Director/Board Member | 64 | 22-12-31 |
Christy Oliger
BRD | Director/Board Member | 54 | 23-03-08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 26,289,087 | 18,738,315 ( 71.28 %) | 0 | 71.28 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.04% | 63.09M | |
+43.36% | 58.06B | |
-5.31% | 40.53B | |
+37.52% | 38.99B | |
+14.75% | 26.7B | |
-12.56% | 26.56B | |
-22.45% | 18.98B | |
+0.04% | 12.17B | |
+25.12% | 12B | |
+26.04% | 11.92B |
- Stock Market
- Equities
- LVTX Stock
- Company LAVA Therapeutics N.V.